Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Hisami Yamanaka‐Okumura"'
Autor:
Ayari Tsumura, Hisami Yamanaka-Okumura, Hana Kawakami, Shiori Yamamoto, Mayu Oura, Hirokazu Ohminami, Masashi Masuda, Yutaka Taketani
Publikováno v:
Human Nutrition & Metabolism, Vol 33, Iss , Pp 200200- (2023)
Objectives: Dietary assessment requires standards, but for the correct evaluation and understanding, not only quantity but also quality; source information is essential. In particular, protein and fat, the major nutrients in the diet, are important t
Externí odkaz:
https://doaj.org/article/cad2ed9b01d049e0b453cbcc4c19deda
Autor:
Kohta Ohnishi, Satoshi Yano, Moe Fujimoto, Maiko Sakai, Erika Harumoto, Airi Furuichi, Masashi Masuda, Hirokazu Ohminami, Hisami Yamanaka-Okumura, Taichi Hara, Yutaka Taketani
Publikováno v:
Antioxidants, Vol 9, Iss 12, p 1193 (2020)
Autophagy is a major degradation system for intracellular macromolecules. Its decline with age or obesity is related to the onset and development of various intractable diseases. Although dietary phytochemicals are expected to enhance autophagy for p
Externí odkaz:
https://doaj.org/article/38fdb309f42e42d0ba6695461e9b7ce3
Autor:
Hitoshi Ozawa, Akiyoshi Hirayama, Futaba Shoji, Midori Maruyama, Kumi Suzuki, Hisami Yamanaka-Okumura, Hiroshi Tatano, Yuji Morine, Tomoyoshi Soga, Mitsuo Shimada, Masaru Tomita
Publikováno v:
Metabolites, Vol 10, Iss 11, p 442 (2020)
As the physical properties and functionality of dipeptides differ from those of amino acids, they have attracted attention in metabolomics; however, their functions in vivo have not been clarified in detail. Hepatocellular carcinoma (HCC) is the most
Externí odkaz:
https://doaj.org/article/cb01d272d53742a9a7159b7d51837d9a
Publikováno v:
Journal of Physical Fitness and Sports Medicine, Vol 2, Iss 4, Pp 409-416 (2013)
Nutrient transporters play significant roles in physiological hormonal and cellular functions as well as in the maintenance of nutrient metabolism. Lifestyle-related disease can be defined as caused by a disturbance in nutrient metabolism as found in
Externí odkaz:
https://doaj.org/article/281b84c598cd4d24b4ba524802cd5794
Autor:
Rui Wang‐Sattler, Zhonghao Yu, Christian Herder, Ana C Messias, Anna Floegel, Ying He, Katharina Heim, Monica Campillos, Christina Holzapfel, Barbara Thorand, Harald Grallert, Tao Xu, Erik Bader, Cornelia Huth, Kirstin Mittelstrass, Angela Döring, Christa Meisinger, Christian Gieger, Cornelia Prehn, Werner Roemisch‐Margl, Maren Carstensen, Lu Xie, Hisami Yamanaka‐Okumura, Guihong Xing, Uta Ceglarek, Joachim Thiery, Guido Giani, Heiko Lickert, Xu Lin, Yixue Li, Heiner Boeing, Hans‐Georg Joost, Martin Hrabé de Angelis, Wolfgang Rathmann, Karsten Suhre, Holger Prokisch, Annette Peters, Thomas Meitinger, Michael Roden, H‐Erich Wichmann, Tobias Pischon, Jerzy Adamski, Thomas Illig
Publikováno v:
Molecular Systems Biology, Vol 8, Iss 1, Pp 1-11 (2012)
Abstract Type 2 diabetes (T2D) can be prevented in pre‐diabetic individuals with impaired glucose tolerance (IGT). Here, we have used a metabolomics approach to identify candidate biomarkers of pre‐diabetes. We quantified 140 metabolites for 4297
Externí odkaz:
https://doaj.org/article/153ef262445a410db6a6526b83de6a11
Autor:
Takashi Uebanso, Yutaka Taketani, Hironori Yamamoto, Kikuko Amo, Hirokazu Ominami, Hidekazu Arai, Yuichiro Takei, Masashi Masuda, Ayako Tanimura, Nagakatsu Harada, Hisami Yamanaka-Okumura, Eiji Takeda
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e22976 (2011)
Fibroblast growth factor 21 (FGF21) has recently emerged as a metabolic hormone involved in regulating glucose and lipid metabolism in mouse, but the regulatory mechanisms and actions of FGF21 in humans remain unclear. Here we have investigated the r
Externí odkaz:
https://doaj.org/article/c74175d39e004a25a8edb88e4752d59e
Autor:
Yuji, Morine, Tohru, Utsunomiya, Hisami, Yamanaka-Okumura, Yu, Saito, Shinichiro, Yamada, Tetsuya, Ikemoto, Satoru, Imura, Shohei, Kinoshita, Akiyoshi, Hirayama, Yasuhito, Tanaka, Mitsuo, Shimada
Publikováno v:
Oncotarget. 13:1286-1298
Metabolomics, defined as the comprehensive identification of all small metabolites in a biological sample, has the power to shed light on phenotypic changes associated with various diseases, including cancer. To discover potential metabolomic biomark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328920932aac8c2485d48af954d38eb5
https://doi.org/10.18632/oncotarget.28306
https://doi.org/10.18632/oncotarget.28306
Autor:
Ana Teresa Limon-Miro, Clive Douglas Jackson, Tannaz Eslamparast, Hisami Yamanaka-Okumura, Lindsay Dudley Plank, Christiani Jeyakumar Henry, Angela Mary Madden, Livia Garcia Ferreira, Evangelos Kalaitzakis, César Prieto de Frías, Anne Wilkens Knudsen, Leah Gramlich, Maitreyi Raman, Cathy Alberda, Dawn Belland, Vanessa Den Heyer, Puneeta Tandon, Marsha Yvonne Morgan
Publikováno v:
Journal of Hepatology. 77:98-107
Malnutrition is associated with adverse clinical outcomes in patients with cirrhosis. Accurate assessment of energy requirements is needed to optimize dietary intake. Resting energy expenditure (REE), the major component of total energy expenditure,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a4f4cd7b2c4bb87886bc4e570d938a
https://doi.org/10.1016/j.jhep.2022.01.005
https://doi.org/10.1016/j.jhep.2022.01.005
Autor:
Yilimulati, Yimamu, Ayako, Ohtani, Yuichiro, Takei, Airi, Furuichi, Yuki, Kamei, Hisami, Yamanaka-Okumura, Hirokazu, Ohminami, Masashi, Masuda, Makoto, Miyazaki, Hironori, Yamamoto, Yutaka, Taketani
Publikováno v:
Journal of Clinical Biochemistry and Nutrition. 71:103-111
Vascular calcification is an important pathogenesis related to cardiovascular disease and high mortality rate in chronic kidney disease (CKD) patients. It has been well-known that hyper-phosphatemia induces osteochondrogenic transition of vascular sm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac0a1dd5e6aacefef40faf30d8e9bb40
https://doi.org/10.3164/jcbn.22-16
https://doi.org/10.3164/jcbn.22-16
Autor:
Mayumi Morinishi, Yuka Fushitani, Mami Matsuno, Misaki Katsumoto, Michiyo Yamasaki, Tsuneyuki Noda, Sachi Nii, Eiji Takeda, Hironori Yamamoto, Hisami Yamanaka-Okumura, Kohei Sugihara, Sayaka Matsuura, Hiroshi Sakaue, Tomomi Nakagawa, Yoko Narasaki, Takeshi Yoneda, Yutaka Taketani, Masashi Masuda
Publikováno v:
Journal of Renal Nutrition. 30:493-502
Objective Dietary phosphorus (P) restriction is crucial to treat hyperphosphatemia and reduce cardiovascular disease risk and mortality in patients with chronic kidney disease (CKD) and the wider population. Various methods for dietary P restriction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af7eeb3b112d7e160f535f9ea2ba20f
https://doi.org/10.1053/j.jrn.2020.02.005
https://doi.org/10.1053/j.jrn.2020.02.005